drugset / Trial / NCT00806221
An Open-Label Study Investigating the Effects of Early Skin Barrier Protection on the Development of Atopic Dermatitis
NaSingle-groupOpen-labelPrevention
Summary
The purpose of this study is to determine whether early use of a bland emollient in newborns, prior to the clinical signs of skin disease, will delay the onset or prevent the development of atopic dermatitis.
Timeline
- Start
- 2006-11
- Primary completion
- 2008-11
- Completion
- 2009-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetaphil cream | Unknown | — | Topical |